Mathematical modeling on helper T cells in a tumor immune system
暂无分享,去创建一个
[1] D. Kirschner,et al. Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.
[2] D. Kirschner,et al. A mathematical model of tumor-immune evasion and siRNA treatment , 2003 .
[3] Magda Galach,et al. DYNAMICS OF THE TUMOR—IMMUNE SYSTEM COMPETITION—THE EFFECT OF TIME DELAY , 2003 .
[4] Olivier Lantz,et al. CD4 cells can be more efficient at tumor rejection than CD8 cells. , 2007 .
[5] Konstantin E. Starkov,et al. Global dynamics of the Kirschner–Panetta model for the tumor immunotherapy , 2013 .
[6] Y. Lai,et al. The Roles of CD4+ T Cells in Tumor Immunity , 2011 .
[7] Zuzanna Szymańska,et al. Analysis of Immunotherapy Models in the Context of Cancer Dynamics , 2003 .
[8] Gail S. K. Wolkowicz,et al. Bifurcation Analysis of a Chemostat Model with a Distributed Delay , 1996 .
[9] D. Kirschner,et al. A Mathematical Model of Gene Therapy for the Treatment of Cancer , 2013 .
[10] Nicola Bellomo,et al. A Survey of Models for Tumor-Immune System Dynamics , 1996 .
[11] Mark A. J. Chaplain,et al. Oscillations and bistability in the dynamics of cytotoxic reactions mediated by the response of immune cells to solid tumours , 2008, Math. Comput. Model..
[12] S. Ruan,et al. Stable periodic oscillations in a two-stage cancer model of tumor and immune system interactions. , 2012, Mathematical biosciences and engineering : MBE.
[13] Steven A. Rosenberg,et al. Progress in human tumour immunology and immunotherapy , 2001, Nature.
[14] D. Earn,et al. Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.
[15] L. D. Pillis,et al. A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .
[16] M C Mackey,et al. Periodic chronic myelogenous leukaemia: spectral analysis of blood cell counts and aetiological implications , 1999, British journal of haematology.
[17] Lloyd J. Old,et al. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.
[18] D. Earn,et al. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. , 2010, Journal of theoretical biology.
[19] R. Noelle,et al. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells , 1998, Journal of leukocyte biology.
[20] Stefano Papa,et al. NK Cells and Cancer1 , 2007, The Journal of Immunology.
[21] K. Honda,et al. Transcriptional Reprogramming of Mature CD4+ T helper Cells generates distinct MHC class II-restricted Cytotoxic T Lymphocytes , 2013, Nature Immunology.
[22] G. Sell,et al. The Hopf Bifurcation and Its Applications , 1976 .
[23] Denise Kirschner,et al. On the global dynamics of a model for tumor immunotherapy. , 2009, Mathematical biosciences and engineering : MBE.
[24] P. Bruggen,et al. Human tumor antigens recognized by T lymphocytes , 1996, The Journal of experimental medicine.
[25] A. Radunskaya,et al. Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .
[26] Bard Ermentrout,et al. Simulating, analyzing, and animating dynamical systems - a guide to XPPAUT for researchers and students , 2002, Software, environments, tools.
[27] L A Aguirre,et al. What can be learned from a chaotic cancer model? , 2013, Journal of theoretical biology.
[28] Shigui Ruan,et al. Bifurcation analysis in models of tumor and immune system interactions , 2009 .
[29] B. Rocha,et al. A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory , 2002, Science.
[30] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[31] C. Lowenstein,et al. The Central Role of CD4+ T Cells in the Antitumor Immune Response , 1998, The Journal of experimental medicine.
[32] L. Coussens,et al. Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.
[33] R. Blasberg,et al. Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts , 2010, The Journal of experimental medicine.
[34] A. d’Onofrio. A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences , 2005, 1309.3337.
[35] Ami Radunskaya,et al. A delay differential equation model for tumor growth , 2003, Journal of mathematical biology.